<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2024-10-02" version="235" xmlns="http://uniprot.org/uniprot">
  <accession>P55265</accession>
  <accession>B1AQQ9</accession>
  <accession>B1AQR0</accession>
  <accession>D3DV76</accession>
  <accession>O15223</accession>
  <accession>O43859</accession>
  <accession>O43860</accession>
  <accession>Q9BYM3</accession>
  <accession>Q9BYM4</accession>
  <name>DSRAD_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>Double-stranded RNA-specific adenosine deaminase</fullName>
      <shortName evidence="40">DRADA</shortName>
      <ecNumber evidence="35 36">3.5.4.37</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>136 kDa double-stranded RNA-binding protein</fullName>
      <shortName>p136</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>Interferon-inducible protein 4</fullName>
      <shortName>IFI-4</shortName>
    </alternativeName>
    <alternativeName>
      <fullName>K88DSRBP</fullName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">ADAR</name>
    <name type="synonym">ADAR1</name>
    <name type="synonym">DSRAD</name>
    <name type="synonym">G1P1</name>
    <name type="synonym">IFI4</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="11457" last="11461">
      <title>Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing.</title>
      <authorList>
        <person name="Kim U."/>
        <person name="Wang Y."/>
        <person name="Sanford T."/>
        <person name="Zeng Y."/>
        <person name="Nishikura K."/>
      </authorList>
      <dbReference type="PubMed" id="7972084"/>
      <dbReference type="DOI" id="10.1073/pnas.91.24.11457"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>PARTIAL PROTEIN SEQUENCE</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <scope>VARIANT GLY-100</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="1995" name="Mol. Cell. Biol." volume="15" first="5376" last="5388">
      <title>Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase.</title>
      <authorList>
        <person name="Patterson J.B."/>
        <person name="Samuel C.E."/>
      </authorList>
      <dbReference type="PubMed" id="7565688"/>
      <dbReference type="DOI" id="10.1128/mcb.15.10.5376"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INDUCTION BY INTERFERON</scope>
    <scope>VARIANTS GLY-100 AND ARG-384</scope>
    <source>
      <tissue>Kidney</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="4419" last="4428">
      <title>Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase.</title>
      <authorList>
        <person name="Liu Y."/>
        <person name="George C.X."/>
        <person name="Patterson J.B."/>
        <person name="Samuel C.E."/>
      </authorList>
      <dbReference type="PubMed" id="9020165"/>
      <dbReference type="DOI" id="10.1074/jbc.272.7.4419"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 2 AND 3)</scope>
    <scope>VARIANTS GLY-100 AND ARG-384</scope>
    <source>
      <tissue>Placenta</tissue>
    </source>
  </reference>
  <reference key="4">
    <citation type="submission" date="1996-06" db="EMBL/GenBank/DDBJ databases">
      <title>The gene coding for the interferon-inducible human dsRNA adenosine deaminase is transcribed into several messengers specifying different proteins.</title>
      <authorList>
        <person name="Deblandre G."/>
        <person name="Marinx O."/>
        <person name="Nols C."/>
        <person name="Defrance P."/>
        <person name="Berr P."/>
        <person name="Huez G."/>
        <person name="Caput D."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 5)</scope>
    <scope>VARIANTS GLY-100 AND ARG-384</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
      <title>The full-ORF clone resource of the German cDNA consortium.</title>
      <authorList>
        <person name="Bechtel S."/>
        <person name="Rosenfelder H."/>
        <person name="Duda A."/>
        <person name="Schmidt C.P."/>
        <person name="Ernst U."/>
        <person name="Wellenreuther R."/>
        <person name="Mehrle A."/>
        <person name="Schuster C."/>
        <person name="Bahr A."/>
        <person name="Bloecker H."/>
        <person name="Heubner D."/>
        <person name="Hoerlein A."/>
        <person name="Michel G."/>
        <person name="Wedler H."/>
        <person name="Koehrer K."/>
        <person name="Ottenwaelder B."/>
        <person name="Poustka A."/>
        <person name="Wiemann S."/>
        <person name="Schupp I."/>
      </authorList>
      <dbReference type="PubMed" id="17974005"/>
      <dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
    <scope>VARIANTS GLY-100 AND ARG-384</scope>
    <source>
      <tissue>Amygdala</tissue>
      <tissue>Fetal kidney</tissue>
    </source>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
      <title>The DNA sequence and biological annotation of human chromosome 1.</title>
      <authorList>
        <person name="Gregory S.G."/>
        <person name="Barlow K.F."/>
        <person name="McLay K.E."/>
        <person name="Kaul R."/>
        <person name="Swarbreck D."/>
        <person name="Dunham A."/>
        <person name="Scott C.E."/>
        <person name="Howe K.L."/>
        <person name="Woodfine K."/>
        <person name="Spencer C.C.A."/>
        <person name="Jones M.C."/>
        <person name="Gillson C."/>
        <person name="Searle S."/>
        <person name="Zhou Y."/>
        <person name="Kokocinski F."/>
        <person name="McDonald L."/>
        <person name="Evans R."/>
        <person name="Phillips K."/>
        <person name="Atkinson A."/>
        <person name="Cooper R."/>
        <person name="Jones C."/>
        <person name="Hall R.E."/>
        <person name="Andrews T.D."/>
        <person name="Lloyd C."/>
        <person name="Ainscough R."/>
        <person name="Almeida J.P."/>
        <person name="Ambrose K.D."/>
        <person name="Anderson F."/>
        <person name="Andrew R.W."/>
        <person name="Ashwell R.I.S."/>
        <person name="Aubin K."/>
        <person name="Babbage A.K."/>
        <person name="Bagguley C.L."/>
        <person name="Bailey J."/>
        <person name="Beasley H."/>
        <person name="Bethel G."/>
        <person name="Bird C.P."/>
        <person name="Bray-Allen S."/>
        <person name="Brown J.Y."/>
        <person name="Brown A.J."/>
        <person name="Buckley D."/>
        <person name="Burton J."/>
        <person name="Bye J."/>
        <person name="Carder C."/>
        <person name="Chapman J.C."/>
        <person name="Clark S.Y."/>
        <person name="Clarke G."/>
        <person name="Clee C."/>
        <person name="Cobley V."/>
        <person name="Collier R.E."/>
        <person name="Corby N."/>
        <person name="Coville G.J."/>
        <person name="Davies J."/>
        <person name="Deadman R."/>
        <person name="Dunn M."/>
        <person name="Earthrowl M."/>
        <person name="Ellington A.G."/>
        <person name="Errington H."/>
        <person name="Frankish A."/>
        <person name="Frankland J."/>
        <person name="French L."/>
        <person name="Garner P."/>
        <person name="Garnett J."/>
        <person name="Gay L."/>
        <person name="Ghori M.R.J."/>
        <person name="Gibson R."/>
        <person name="Gilby L.M."/>
        <person name="Gillett W."/>
        <person name="Glithero R.J."/>
        <person name="Grafham D.V."/>
        <person name="Griffiths C."/>
        <person name="Griffiths-Jones S."/>
        <person name="Grocock R."/>
        <person name="Hammond S."/>
        <person name="Harrison E.S.I."/>
        <person name="Hart E."/>
        <person name="Haugen E."/>
        <person name="Heath P.D."/>
        <person name="Holmes S."/>
        <person name="Holt K."/>
        <person name="Howden P.J."/>
        <person name="Hunt A.R."/>
        <person name="Hunt S.E."/>
        <person name="Hunter G."/>
        <person name="Isherwood J."/>
        <person name="James R."/>
        <person name="Johnson C."/>
        <person name="Johnson D."/>
        <person name="Joy A."/>
        <person name="Kay M."/>
        <person name="Kershaw J.K."/>
        <person name="Kibukawa M."/>
        <person name="Kimberley A.M."/>
        <person name="King A."/>
        <person name="Knights A.J."/>
        <person name="Lad H."/>
        <person name="Laird G."/>
        <person name="Lawlor S."/>
        <person name="Leongamornlert D.A."/>
        <person name="Lloyd D.M."/>
        <person name="Loveland J."/>
        <person name="Lovell J."/>
        <person name="Lush M.J."/>
        <person name="Lyne R."/>
        <person name="Martin S."/>
        <person name="Mashreghi-Mohammadi M."/>
        <person name="Matthews L."/>
        <person name="Matthews N.S.W."/>
        <person name="McLaren S."/>
        <person name="Milne S."/>
        <person name="Mistry S."/>
        <person name="Moore M.J.F."/>
        <person name="Nickerson T."/>
        <person name="O'Dell C.N."/>
        <person name="Oliver K."/>
        <person name="Palmeiri A."/>
        <person name="Palmer S.A."/>
        <person name="Parker A."/>
        <person name="Patel D."/>
        <person name="Pearce A.V."/>
        <person name="Peck A.I."/>
        <person name="Pelan S."/>
        <person name="Phelps K."/>
        <person name="Phillimore B.J."/>
        <person name="Plumb R."/>
        <person name="Rajan J."/>
        <person name="Raymond C."/>
        <person name="Rouse G."/>
        <person name="Saenphimmachak C."/>
        <person name="Sehra H.K."/>
        <person name="Sheridan E."/>
        <person name="Shownkeen R."/>
        <person name="Sims S."/>
        <person name="Skuce C.D."/>
        <person name="Smith M."/>
        <person name="Steward C."/>
        <person name="Subramanian S."/>
        <person name="Sycamore N."/>
        <person name="Tracey A."/>
        <person name="Tromans A."/>
        <person name="Van Helmond Z."/>
        <person name="Wall M."/>
        <person name="Wallis J.M."/>
        <person name="White S."/>
        <person name="Whitehead S.L."/>
        <person name="Wilkinson J.E."/>
        <person name="Willey D.L."/>
        <person name="Williams H."/>
        <person name="Wilming L."/>
        <person name="Wray P.W."/>
        <person name="Wu Z."/>
        <person name="Coulson A."/>
        <person name="Vaudin M."/>
        <person name="Sulston J.E."/>
        <person name="Durbin R.M."/>
        <person name="Hubbard T."/>
        <person name="Wooster R."/>
        <person name="Dunham I."/>
        <person name="Carter N.P."/>
        <person name="McVean G."/>
        <person name="Ross M.T."/>
        <person name="Harrow J."/>
        <person name="Olson M.V."/>
        <person name="Beck S."/>
        <person name="Rogers J."/>
        <person name="Bentley D.R."/>
      </authorList>
      <dbReference type="PubMed" id="16710414"/>
      <dbReference type="DOI" id="10.1038/nature04727"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="7">
    <citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <scope>VARIANT GLY-100</scope>
    <source>
      <tissue>Lymph</tissue>
    </source>
  </reference>
  <reference key="9">
    <citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="4621" last="4626">
      <title>Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible.</title>
      <authorList>
        <person name="George C.X."/>
        <person name="Samuel C.E."/>
      </authorList>
      <dbReference type="PubMed" id="10200312"/>
      <dbReference type="DOI" id="10.1073/pnas.96.8.4621"/>
    </citation>
    <scope>ALTERNATIVE PROMOTER USAGE</scope>
    <scope>INDUCTION</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="17093" last="17102">
      <title>Requirement of dimerization for RNA editing activity of adenosine deaminases acting on RNA.</title>
      <authorList>
        <person name="Cho D.-S.C."/>
        <person name="Yang W."/>
        <person name="Lee J.T."/>
        <person name="Shiekhattar R."/>
        <person name="Murray J.M."/>
        <person name="Nishikura K."/>
      </authorList>
      <dbReference type="PubMed" id="12618436"/>
      <dbReference type="DOI" id="10.1074/jbc.m213127200"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>HOMODIMERIZATION</scope>
    <scope>SUBUNIT</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2003" name="J. Cell Sci." volume="116" first="1805" last="1818">
      <title>Dynamic association of RNA-editing enzymes with the nucleolus.</title>
      <authorList>
        <person name="Desterro J.M.P."/>
        <person name="Keegan L.P."/>
        <person name="Lafarga M."/>
        <person name="Berciano M.T."/>
        <person name="O'Connell M."/>
        <person name="Carmo-Fonseca M."/>
      </authorList>
      <dbReference type="PubMed" id="12665561"/>
      <dbReference type="DOI" id="10.1242/jcs.00371"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="3946" last="3953">
      <title>ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells.</title>
      <authorList>
        <person name="Yang W."/>
        <person name="Wang Q."/>
        <person name="Howell K.L."/>
        <person name="Lee J.T."/>
        <person name="Cho D.-S.C."/>
        <person name="Murray J.M."/>
        <person name="Nishikura K."/>
      </authorList>
      <dbReference type="PubMed" id="15556947"/>
      <dbReference type="DOI" id="10.1074/jbc.m407876200"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2005" name="J. Virol." volume="79" first="6291" last="6298">
      <title>New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1.</title>
      <authorList>
        <person name="Taylor D.R."/>
        <person name="Puig M."/>
        <person name="Darnell M.E."/>
        <person name="Mihalik K."/>
        <person name="Feinstone S.M."/>
      </authorList>
      <dbReference type="PubMed" id="15858013"/>
      <dbReference type="DOI" id="10.1128/jvi.79.10.6291-6298.2005"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="5115" last="5126">
      <title>SUMO-1 modification alters ADAR1 editing activity.</title>
      <authorList>
        <person name="Desterro J.M.P."/>
        <person name="Keegan L.P."/>
        <person name="Jaffray E."/>
        <person name="Hay R.T."/>
        <person name="O'Connell M.A."/>
        <person name="Carmo-Fonseca M."/>
      </authorList>
      <dbReference type="PubMed" id="16120648"/>
      <dbReference type="DOI" id="10.1091/mbc.e05-06-0536"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUMOYLATION AT LYS-418</scope>
    <scope>MUTAGENESIS OF LYS-418</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="6956" last="6963">
      <title>ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing.</title>
      <authorList>
        <person name="Nie Y."/>
        <person name="Ding L."/>
        <person name="Kao P.N."/>
        <person name="Braun R."/>
        <person name="Yang J.-H."/>
      </authorList>
      <dbReference type="PubMed" id="16055709"/>
      <dbReference type="DOI" id="10.1128/mcb.25.16.6956-6963.2005"/>
    </citation>
    <scope>INTERACTION WITH ILF2 AND ILF3</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2006" name="J. Viral Hepat." volume="13" first="150" last="157">
      <title>The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells.</title>
      <authorList>
        <person name="Hartwig D."/>
        <person name="Schuette C."/>
        <person name="Warnecke J."/>
        <person name="Dorn I."/>
        <person name="Hennig H."/>
        <person name="Kirchner H."/>
        <person name="Schlenke P."/>
      </authorList>
      <dbReference type="PubMed" id="16475990"/>
      <dbReference type="DOI" id="10.1111/j.1365-2893.2005.00663.x"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
      <title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
      <authorList>
        <person name="Beausoleil S.A."/>
        <person name="Villen J."/>
        <person name="Gerber S.A."/>
        <person name="Rush J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="16964243"/>
      <dbReference type="DOI" id="10.1038/nbt1240"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-808</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
      <title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
      <authorList>
        <person name="Yu L.R."/>
        <person name="Zhu Z."/>
        <person name="Chan K.C."/>
        <person name="Issaq H.J."/>
        <person name="Dimitrov D.S."/>
        <person name="Veenstra T.D."/>
      </authorList>
      <dbReference type="PubMed" id="17924679"/>
      <dbReference type="DOI" id="10.1021/pr070152u"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-808</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2007" name="J. Virol." volume="81" first="917" last="923">
      <title>Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection.</title>
      <authorList>
        <person name="Nie Y."/>
        <person name="Hammond G.L."/>
        <person name="Yang J.H."/>
      </authorList>
      <dbReference type="PubMed" id="17079286"/>
      <dbReference type="DOI" id="10.1128/jvi.01527-06"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH EIF2AK2</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="7251" last="7260">
      <title>Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation.</title>
      <authorList>
        <person name="Cenci C."/>
        <person name="Barzotti R."/>
        <person name="Galeano F."/>
        <person name="Corbelli S."/>
        <person name="Rota R."/>
        <person name="Massimi L."/>
        <person name="Di Rocco C."/>
        <person name="O'Connell M.A."/>
        <person name="Gallo A."/>
      </authorList>
      <dbReference type="PubMed" id="18178553"/>
      <dbReference type="DOI" id="10.1074/jbc.m708316200"/>
    </citation>
    <scope>ALTERNATIVE SPLICING</scope>
    <scope>SUBUNIT</scope>
    <scope>TISSUE SPECIFICITY</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
      <title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
      <authorList>
        <person name="Cantin G.T."/>
        <person name="Yi W."/>
        <person name="Lu B."/>
        <person name="Park S.K."/>
        <person name="Xu T."/>
        <person name="Lee J.-D."/>
        <person name="Yates J.R. III"/>
      </authorList>
      <dbReference type="PubMed" id="18220336"/>
      <dbReference type="DOI" id="10.1021/pr0705441"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-808</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
      <title>A quantitative atlas of mitotic phosphorylation.</title>
      <authorList>
        <person name="Dephoure N."/>
        <person name="Zhou C."/>
        <person name="Villen J."/>
        <person name="Beausoleil S.A."/>
        <person name="Bakalarski C.E."/>
        <person name="Elledge S.J."/>
        <person name="Gygi S.P."/>
      </authorList>
      <dbReference type="PubMed" id="18669648"/>
      <dbReference type="DOI" id="10.1073/pnas.0805139105"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-601; SER-614; SER-823 AND SER-825</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="5028" last="5033">
      <title>The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus.</title>
      <authorList>
        <person name="Agranat L."/>
        <person name="Raitskin O."/>
        <person name="Sperling J."/>
        <person name="Sperling R."/>
      </authorList>
      <dbReference type="PubMed" id="18362360"/>
      <dbReference type="DOI" id="10.1073/pnas.0710576105"/>
    </citation>
    <scope>INTERACTION WITH UPF1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
      <title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
      <authorList>
        <person name="Gauci S."/>
        <person name="Helbig A.O."/>
        <person name="Slijper M."/>
        <person name="Krijgsveld J."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="19413330"/>
      <dbReference type="DOI" id="10.1021/ac9004309"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="29350" last="29356">
      <title>RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.</title>
      <authorList>
        <person name="Toth A.M."/>
        <person name="Li Z."/>
        <person name="Cattaneo R."/>
        <person name="Samuel C.E."/>
      </authorList>
      <dbReference type="PubMed" id="19710021"/>
      <dbReference type="DOI" id="10.1074/jbc.m109.045146"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="26">
    <citation type="journal article" date="2009" name="J. Virol." volume="83" first="10119" last="10128">
      <title>ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.</title>
      <authorList>
        <person name="Clerzius G."/>
        <person name="Gelinas J.F."/>
        <person name="Daher A."/>
        <person name="Bonnet M."/>
        <person name="Meurs E.F."/>
        <person name="Gatignol A."/>
      </authorList>
      <dbReference type="PubMed" id="19605474"/>
      <dbReference type="DOI" id="10.1128/jvi.02457-08"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH EIF2AK2</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="1487" last="1497">
      <title>RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1.</title>
      <authorList>
        <person name="Fritz J."/>
        <person name="Strehblow A."/>
        <person name="Taschner A."/>
        <person name="Schopoff S."/>
        <person name="Pasierbek P."/>
        <person name="Jantsch M.F."/>
      </authorList>
      <dbReference type="PubMed" id="19124606"/>
      <dbReference type="DOI" id="10.1128/mcb.01519-08"/>
    </citation>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH TNPO1 AND XPO5</scope>
    <scope>DOMAIN</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="5848" last="5858">
      <title>Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection.</title>
      <authorList>
        <person name="Doria M."/>
        <person name="Neri F."/>
        <person name="Gallo A."/>
        <person name="Farace M.G."/>
        <person name="Michienzi A."/>
      </authorList>
      <dbReference type="PubMed" id="19651874"/>
      <dbReference type="DOI" id="10.1093/nar/gkp604"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
      <title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
      <authorList>
        <person name="Mayya V."/>
        <person name="Lundgren D.H."/>
        <person name="Hwang S.-I."/>
        <person name="Rezaul K."/>
        <person name="Wu L."/>
        <person name="Eng J.K."/>
        <person name="Rodionov V."/>
        <person name="Han D.K."/>
      </authorList>
      <dbReference type="PubMed" id="19690332"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000007"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-601 AND THR-808</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Leukemic T-cell</tissue>
    </source>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2010" name="Annu. Rev. Biochem." volume="79" first="321" last="349">
      <title>Functions and regulation of RNA editing by ADAR deaminases.</title>
      <authorList>
        <person name="Nishikura K."/>
      </authorList>
      <dbReference type="PubMed" id="20192758"/>
      <dbReference type="DOI" id="10.1146/annurev-biochem-060208-105251"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2010" name="Int. J. Cancer" volume="127" first="127" last="137">
      <title>Human BLCAP transcript: new editing events in normal and cancerous tissues.</title>
      <authorList>
        <person name="Galeano F."/>
        <person name="Leroy A."/>
        <person name="Rossetti C."/>
        <person name="Gromova I."/>
        <person name="Gautier P."/>
        <person name="Keegan L.P."/>
        <person name="Massimi L."/>
        <person name="Di Rocco C."/>
        <person name="O'Connell M.A."/>
        <person name="Gallo A."/>
      </authorList>
      <dbReference type="PubMed" id="19908260"/>
      <dbReference type="DOI" id="10.1002/ijc.25022"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="32">
    <citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
      <title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
      <authorList>
        <person name="Olsen J.V."/>
        <person name="Vermeulen M."/>
        <person name="Santamaria A."/>
        <person name="Kumar C."/>
        <person name="Miller M.L."/>
        <person name="Jensen L.J."/>
        <person name="Gnad F."/>
        <person name="Cox J."/>
        <person name="Jensen T.S."/>
        <person name="Nigg E.A."/>
        <person name="Brunak S."/>
        <person name="Mann M."/>
      </authorList>
      <dbReference type="PubMed" id="20068231"/>
      <dbReference type="DOI" id="10.1126/scisignal.2000475"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-808 AND SER-825</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="33">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="34">
    <citation type="journal article" date="2011" name="Biochemistry (Mosc.)" volume="76" first="900" last="911">
      <title>RNA editing catalyzed by ADAR1 and its function in mammalian cells.</title>
      <authorList>
        <person name="Wang Q."/>
      </authorList>
      <dbReference type="PubMed" id="22022963"/>
      <dbReference type="DOI" id="10.1134/s0006297911080050"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="35">
    <citation type="journal article" date="2011" name="J. Gen. Virol." volume="92" first="1228" last="1232">
      <title>ADAR2 editing enzyme is a novel human immunodeficiency virus-1 proviral factor.</title>
      <authorList>
        <person name="Doria M."/>
        <person name="Tomaselli S."/>
        <person name="Neri F."/>
        <person name="Ciafre S.A."/>
        <person name="Farace M.G."/>
        <person name="Michienzi A."/>
        <person name="Gallo A."/>
      </authorList>
      <dbReference type="PubMed" id="21289159"/>
      <dbReference type="DOI" id="10.1099/vir.0.028043-0"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="36">
    <citation type="journal article" date="2011" name="J. Interferon Cytokine Res." volume="31" first="99" last="117">
      <title>Adenosine deaminases acting on RNA, RNA editing, and interferon action.</title>
      <authorList>
        <person name="George C.X."/>
        <person name="Gan Z."/>
        <person name="Liu Y."/>
        <person name="Samuel C.E."/>
      </authorList>
      <dbReference type="PubMed" id="21182352"/>
      <dbReference type="DOI" id="10.1089/jir.2010.0097"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="37">
    <citation type="journal article" date="2011" name="J. Virol." volume="85" first="8460" last="8466">
      <title>Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.</title>
      <authorList>
        <person name="Gelinas J.F."/>
        <person name="Clerzius G."/>
        <person name="Shaw E."/>
        <person name="Gatignol A."/>
      </authorList>
      <dbReference type="PubMed" id="21490091"/>
      <dbReference type="DOI" id="10.1128/jvi.00240-11"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="38">
    <citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
      <title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
      <authorList>
        <person name="Rigbolt K.T."/>
        <person name="Prokhorova T.A."/>
        <person name="Akimov V."/>
        <person name="Henningsen J."/>
        <person name="Johansen P.T."/>
        <person name="Kratchmarova I."/>
        <person name="Kassem M."/>
        <person name="Mann M."/>
        <person name="Olsen J.V."/>
        <person name="Blagoev B."/>
      </authorList>
      <dbReference type="PubMed" id="21406692"/>
      <dbReference type="DOI" id="10.1126/scisignal.2001570"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-825</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="39">
    <citation type="journal article" date="2011" name="Virology" volume="411" first="180" last="193">
      <title>Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.</title>
      <authorList>
        <person name="Samuel C.E."/>
      </authorList>
      <dbReference type="PubMed" id="21211811"/>
      <dbReference type="DOI" id="10.1016/j.virol.2010.12.004"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="40">
    <citation type="journal article" date="2012" name="Crit. Rev. Biochem. Mol. Biol." volume="47" first="493" last="501">
      <title>A-to-I editing of protein coding and noncoding RNAs.</title>
      <authorList>
        <person name="Mallela A."/>
        <person name="Nishikura K."/>
      </authorList>
      <dbReference type="PubMed" id="22988838"/>
      <dbReference type="DOI" id="10.3109/10409238.2012.714350"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="41">
    <citation type="journal article" date="2012" name="Curr. Top. Microbiol. Immunol." volume="353" first="1" last="33">
      <title>ADAR proteins: structure and catalytic mechanism.</title>
      <authorList>
        <person name="Goodman R.A."/>
        <person name="Macbeth M.R."/>
        <person name="Beal P.A."/>
      </authorList>
      <dbReference type="PubMed" id="21769729"/>
      <dbReference type="DOI" id="10.1007/82_2011_144"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="42">
    <citation type="journal article" date="2012" name="J. Virol." volume="86" first="3787" last="3794">
      <title>Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.</title>
      <authorList>
        <person name="Li Z."/>
        <person name="Okonski K.M."/>
        <person name="Samuel C.E."/>
      </authorList>
      <dbReference type="PubMed" id="22278222"/>
      <dbReference type="DOI" id="10.1128/jvi.06307-11"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="43">
    <citation type="journal article" date="2012" name="Mol. Neurobiol." volume="45" first="61" last="75">
      <title>Activity regulation of adenosine deaminases acting on RNA (ADARs).</title>
      <authorList>
        <person name="Orlandi C."/>
        <person name="Barbon A."/>
        <person name="Barlati S."/>
      </authorList>
      <dbReference type="PubMed" id="22113393"/>
      <dbReference type="DOI" id="10.1007/s12035-011-8220-2"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="44">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-481; THR-601; THR-603; SER-629; SER-636; THR-808; SER-814 AND SER-825</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
      <tissue>Erythroleukemia</tissue>
    </source>
  </reference>
  <reference key="45">
    <citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
      <title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
      <authorList>
        <person name="Bian Y."/>
        <person name="Song C."/>
        <person name="Cheng K."/>
        <person name="Dong M."/>
        <person name="Wang F."/>
        <person name="Huang J."/>
        <person name="Sun D."/>
        <person name="Wang L."/>
        <person name="Ye M."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="24275569"/>
      <dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="46">
    <citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
      <title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
      <authorList>
        <person name="Guo A."/>
        <person name="Gu H."/>
        <person name="Zhou J."/>
        <person name="Mulhern D."/>
        <person name="Wang Y."/>
        <person name="Lee K.A."/>
        <person name="Yang V."/>
        <person name="Aguiar M."/>
        <person name="Kornhauser J."/>
        <person name="Jia X."/>
        <person name="Ren J."/>
        <person name="Beausoleil S.A."/>
        <person name="Silva J.C."/>
        <person name="Vemulapalli V."/>
        <person name="Bedford M.T."/>
        <person name="Comb M.J."/>
      </authorList>
      <dbReference type="PubMed" id="24129315"/>
      <dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
    </citation>
    <scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-26</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Colon carcinoma</tissue>
    </source>
  </reference>
  <reference key="47">
    <citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
      <title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
      <authorList>
        <person name="Impens F."/>
        <person name="Radoshevich L."/>
        <person name="Cossart P."/>
        <person name="Ribet D."/>
      </authorList>
      <dbReference type="PubMed" id="25114211"/>
      <dbReference type="DOI" id="10.1073/pnas.1413825111"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-418</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="48">
    <citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
      <title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
      <authorList>
        <person name="Xiao Z."/>
        <person name="Chang J.G."/>
        <person name="Hendriks I.A."/>
        <person name="Sigurdsson J.O."/>
        <person name="Olsen J.V."/>
        <person name="Vertegaal A.C."/>
      </authorList>
      <dbReference type="PubMed" id="25755297"/>
      <dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-418</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="49">
    <citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
      <title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
      <authorList>
        <person name="Hendriks I.A."/>
        <person name="Lyon D."/>
        <person name="Young C."/>
        <person name="Jensen L.J."/>
        <person name="Vertegaal A.C."/>
        <person name="Nielsen M.L."/>
      </authorList>
      <dbReference type="PubMed" id="28112733"/>
      <dbReference type="DOI" id="10.1038/nsmb.3366"/>
    </citation>
    <scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-384; LYS-408; LYS-418; LYS-580 AND LYS-875</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="50">
    <citation type="journal article" date="1999" name="Science" volume="284" first="1841" last="1845">
      <title>Crystal structure of the Z alpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA.</title>
      <authorList>
        <person name="Schwartz T."/>
        <person name="Rould M.A."/>
        <person name="Lowenhaupt K."/>
        <person name="Herbert A."/>
        <person name="Rich A."/>
      </authorList>
      <dbReference type="PubMed" id="10364558"/>
      <dbReference type="DOI" id="10.1126/science.284.5421.1841"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 133-209 IN COMPLEX WITH Z-DNA</scope>
    <scope>DOMAIN</scope>
  </reference>
  <reference key="51">
    <citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="12465" last="12470">
      <title>The solution structure of the Zalpha domain of the human RNA editing enzyme ADAR1 reveals a prepositioned binding surface for Z-DNA.</title>
      <authorList>
        <person name="Schade M."/>
        <person name="Turner C.J."/>
        <person name="Kuehne R."/>
        <person name="Schmieder P."/>
        <person name="Lowenhaupt K."/>
        <person name="Herbert A."/>
        <person name="Rich A."/>
        <person name="Oschkinat H."/>
      </authorList>
      <dbReference type="PubMed" id="10535945"/>
      <dbReference type="DOI" id="10.1073/pnas.96.22.12465"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 125-201 IN COMPLEX WITH Z-DNA AND ALONE</scope>
    <scope>DOMAIN</scope>
  </reference>
  <reference evidence="43" key="52">
    <citation type="journal article" date="2005" name="Nature" volume="437" first="1183" last="1186">
      <title>Crystal structure of a junction between B-DNA and Z-DNA reveals two extruded bases.</title>
      <authorList>
        <person name="Ha S.C."/>
        <person name="Lowenhaupt K."/>
        <person name="Rich A."/>
        <person name="Kim Y.G."/>
        <person name="Kim K.K."/>
      </authorList>
      <dbReference type="PubMed" id="16237447"/>
      <dbReference type="DOI" id="10.1038/nature04088"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 140-202 IN COMPLEX WITH DNA</scope>
    <scope>DOMAIN</scope>
  </reference>
  <reference key="53">
    <citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="E1852" last="E1861">
      <title>A bimodular nuclear localization signal assembled via an extended double-stranded RNA-binding domain acts as an RNA-sensing signal for transportin 1.</title>
      <authorList>
        <person name="Barraud P."/>
        <person name="Banerjee S."/>
        <person name="Mohamed W.I."/>
        <person name="Jantsch M.F."/>
        <person name="Allain F.H."/>
      </authorList>
      <dbReference type="PubMed" id="24753571"/>
      <dbReference type="DOI" id="10.1073/pnas.1323698111"/>
    </citation>
    <scope>STRUCTURE BY NMR OF 708-801</scope>
    <scope>DOMAIN</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH TNPO1</scope>
    <scope>MUTAGENESIS OF 708-MET--PRO-710; 708-MET--ARG-801; 712-LYS--LYS-715; 716-ILE--ASN-724; ILE-716; GLU-718; LEU-719; ARG-721; LEU-723; ASN-724; 725-THR--ARG-801; 777-LYS-LYS-778 AND ARG-801</scope>
  </reference>
  <reference key="54">
    <citation type="journal article" date="2003" name="Am. J. Hum. Genet." volume="73" first="693" last="699">
      <title>Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria.</title>
      <authorList>
        <person name="Miyamura Y."/>
        <person name="Suzuki T."/>
        <person name="Kono M."/>
        <person name="Inagaki K."/>
        <person name="Ito S."/>
        <person name="Suzuki N."/>
        <person name="Tomita Y."/>
      </authorList>
      <dbReference type="PubMed" id="12916015"/>
      <dbReference type="DOI" id="10.1086/378209"/>
    </citation>
    <scope>VARIANTS DSH PRO-923 AND SER-1165</scope>
  </reference>
  <reference key="55">
    <citation type="journal article" date="2004" name="Hum. Mutat." volume="23" first="629" last="630">
      <title>Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH).</title>
      <authorList>
        <person name="Zhang X.-J."/>
        <person name="He P.-P."/>
        <person name="Li M."/>
        <person name="He C.-D."/>
        <person name="Yan K.-L."/>
        <person name="Cui Y."/>
        <person name="Yang S."/>
        <person name="Zhang K.-Y."/>
        <person name="Gao M."/>
        <person name="Chen J.-J."/>
        <person name="Li C.-R."/>
        <person name="Jin L."/>
        <person name="Chen H.-D."/>
        <person name="Xu S.-J."/>
        <person name="Huang W."/>
      </authorList>
      <dbReference type="PubMed" id="15146470"/>
      <dbReference type="DOI" id="10.1002/humu.9246"/>
    </citation>
    <scope>VARIANT DSH PHE-966</scope>
  </reference>
  <reference key="56">
    <citation type="journal article" date="2005" name="J. Dermatol. Sci." volume="37" first="95" last="99">
      <title>A new arginine substitution mutation of DSRAD gene in a Chinese family with dyschromatosis symmetrica hereditaria.</title>
      <authorList>
        <person name="Li C.-R."/>
        <person name="Li M."/>
        <person name="Ma H.-J."/>
        <person name="Luo D."/>
        <person name="Yang L.-J."/>
        <person name="Wang D.-G."/>
        <person name="Zhu X.-H."/>
        <person name="Yue X.-Z."/>
        <person name="Chen W.-Q."/>
        <person name="Zhu W.-Y."/>
      </authorList>
      <dbReference type="PubMed" id="15659327"/>
      <dbReference type="DOI" id="10.1016/j.jdermsci.2004.11.004"/>
    </citation>
    <scope>VARIANT DSH TRP-1155</scope>
  </reference>
  <reference key="57">
    <citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
      <title>The consensus coding sequences of human breast and colorectal cancers.</title>
      <authorList>
        <person name="Sjoeblom T."/>
        <person name="Jones S."/>
        <person name="Wood L.D."/>
        <person name="Parsons D.W."/>
        <person name="Lin J."/>
        <person name="Barber T.D."/>
        <person name="Mandelker D."/>
        <person name="Leary R.J."/>
        <person name="Ptak J."/>
        <person name="Silliman N."/>
        <person name="Szabo S."/>
        <person name="Buckhaults P."/>
        <person name="Farrell C."/>
        <person name="Meeh P."/>
        <person name="Markowitz S.D."/>
        <person name="Willis J."/>
        <person name="Dawson D."/>
        <person name="Willson J.K.V."/>
        <person name="Gazdar A.F."/>
        <person name="Hartigan J."/>
        <person name="Wu L."/>
        <person name="Liu C."/>
        <person name="Parmigiani G."/>
        <person name="Park B.H."/>
        <person name="Bachman K.E."/>
        <person name="Papadopoulos N."/>
        <person name="Vogelstein B."/>
        <person name="Kinzler K.W."/>
        <person name="Velculescu V.E."/>
      </authorList>
      <dbReference type="PubMed" id="16959974"/>
      <dbReference type="DOI" id="10.1126/science.1133427"/>
    </citation>
    <scope>VARIANT [LARGE SCALE ANALYSIS] VAL-806</scope>
  </reference>
  <reference key="58">
    <citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="1243" last="1248">
      <title>Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature.</title>
      <authorList>
        <person name="Rice G.I."/>
        <person name="Kasher P.R."/>
        <person name="Forte G.M."/>
        <person name="Mannion N.M."/>
        <person name="Greenwood S.M."/>
        <person name="Szynkiewicz M."/>
        <person name="Dickerson J.E."/>
        <person name="Bhaskar S.S."/>
        <person name="Zampini M."/>
        <person name="Briggs T.A."/>
        <person name="Jenkinson E.M."/>
        <person name="Bacino C.A."/>
        <person name="Battini R."/>
        <person name="Bertini E."/>
        <person name="Brogan P.A."/>
        <person name="Brueton L.A."/>
        <person name="Carpanelli M."/>
        <person name="De Laet C."/>
        <person name="de Lonlay P."/>
        <person name="del Toro M."/>
        <person name="Desguerre I."/>
        <person name="Fazzi E."/>
        <person name="Garcia-Cazorla A."/>
        <person name="Heiberg A."/>
        <person name="Kawaguchi M."/>
        <person name="Kumar R."/>
        <person name="Lin J.P."/>
        <person name="Lourenco C.M."/>
        <person name="Male A.M."/>
        <person name="Marques W. Jr."/>
        <person name="Mignot C."/>
        <person name="Olivieri I."/>
        <person name="Orcesi S."/>
        <person name="Prabhakar P."/>
        <person name="Rasmussen M."/>
        <person name="Robinson R.A."/>
        <person name="Rozenberg F."/>
        <person name="Schmidt J.L."/>
        <person name="Steindl K."/>
        <person name="Tan T.Y."/>
        <person name="van der Merwe W.G."/>
        <person name="Vanderver A."/>
        <person name="Vassallo G."/>
        <person name="Wakeling E.L."/>
        <person name="Wassmer E."/>
        <person name="Whittaker E."/>
        <person name="Livingston J.H."/>
        <person name="Lebon P."/>
        <person name="Suzuki T."/>
        <person name="McLaughlin P.J."/>
        <person name="Keegan L.P."/>
        <person name="O'Connell M.A."/>
        <person name="Lovell S.C."/>
        <person name="Crow Y.J."/>
      </authorList>
      <dbReference type="PubMed" id="23001123"/>
      <dbReference type="DOI" id="10.1038/ng.2414"/>
    </citation>
    <scope>VARIANTS AGS6 ALA-193; THR-870; THR-872; HIS-892; ASN-999; ARG-1007; PHE-1112 AND HIS-1113</scope>
  </reference>
  <comment type="function">
    <text evidence="9 14 16 18 20 22 27 28 29 30 31 32 35 36">Catalyzes the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) referred to as A-to-I RNA editing (PubMed:12618436, PubMed:7565688, PubMed:7972084). This may affect gene expression and function in a number of ways that include mRNA translation by changing codons and hence the amino acid sequence of proteins since the translational machinery read the inosine as a guanosine; pre-mRNA splicing by altering splice site recognition sequences; RNA stability by changing sequences involved in nuclease recognition; genetic stability in the case of RNA virus genomes by changing sequences during viral RNA replication; and RNA structure-dependent activities such as microRNA production or targeting or protein-RNA interactions. Can edit both viral and cellular RNAs and can edit RNAs at multiple sites (hyper-editing) or at specific sites (site-specific editing). Its cellular RNA substrates include: bladder cancer-associated protein (BLCAP), neurotransmitter receptors for glutamate (GRIA2) and serotonin (HTR2C) and GABA receptor (GABRA3). Site-specific RNA editing of transcripts encoding these proteins results in amino acid substitutions which consequently alters their functional activities. Exhibits low-level editing at the GRIA2 Q/R site, but edits efficiently at the R/G site and HOTSPOT1. Its viral RNA substrates include: hepatitis C virus (HCV), vesicular stomatitis virus (VSV), measles virus (MV), hepatitis delta virus (HDV), and human immunodeficiency virus type 1 (HIV-1). Exhibits either a proviral (HDV, MV, VSV and HIV-1) or an antiviral effect (HCV) and this can be editing-dependent (HDV and HCV), editing-independent (VSV and MV) or both (HIV-1). Impairs HCV replication via RNA editing at multiple sites. Enhances the replication of MV, VSV and HIV-1 through an editing-independent mechanism via suppression of EIF2AK2/PKR activation and function. Stimulates both the release and infectivity of HIV-1 viral particles by an editing-dependent mechanism where it associates with viral RNAs and edits adenosines in the 5'UTR and the Rev and Tat coding sequence. Can enhance viral replication of HDV via A-to-I editing at a site designated as amber/W, thereby changing an UAG amber stop codon to an UIG tryptophan (W) codon that permits synthesis of the large delta antigen (L-HDAg) which has a key role in the assembly of viral particles. However, high levels of ADAR1 inhibit HDV replication.</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="9 35 36">
      <text>adenosine in double-stranded RNA + H(+) + H2O = inosine in double-stranded RNA + NH4(+)</text>
      <dbReference type="Rhea" id="RHEA:10120"/>
      <dbReference type="Rhea" id="RHEA-COMP:13885"/>
      <dbReference type="Rhea" id="RHEA-COMP:13886"/>
      <dbReference type="ChEBI" id="CHEBI:15377"/>
      <dbReference type="ChEBI" id="CHEBI:15378"/>
      <dbReference type="ChEBI" id="CHEBI:28938"/>
      <dbReference type="ChEBI" id="CHEBI:74411"/>
      <dbReference type="ChEBI" id="CHEBI:82852"/>
      <dbReference type="EC" id="3.5.4.37"/>
    </reaction>
  </comment>
  <comment type="subunit">
    <text evidence="7 8 9 17 22 24 25 26 27 34">Homodimer. Homodimerization is essential for its catalytic activity (PubMed:12618436). Isoform 5 can form heterodimers with ADARB1/ADAR2. Isoform 1 interacts with ILF2/NF45 and ILF3/NF90 (PubMed:16055709). Binding to ILF3/NF90 up-regulates ILF3-mediated gene expression. Isoform 1 and isoform 5 (via DRBM 3 domain) interact with TNPO1 (PubMed:19124606, PubMed:24753571). Isoform 5 (via DRBM domains) interacts with XPO5 (PubMed:19124606). Isoform 1 and isoform 5 can interact with EIF2AK2/PKR and UPF1 (PubMed:17079286, PubMed:18362360).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2462104">
      <id>P55265</id>
    </interactant>
    <interactant intactId="EBI-372899">
      <id>Q13148</id>
      <label>TARDBP</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2462104">
      <id>P55265</id>
    </interactant>
    <interactant intactId="EBI-373471">
      <id>Q92900</id>
      <label>UPF1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2462104">
      <id>P55265</id>
    </interactant>
    <interactant intactId="EBI-2547442">
      <id>P03496</id>
      <label>NS</label>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>8</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2462104">
      <id>P55265</id>
    </interactant>
    <interactant intactId="EBI-9825968">
      <id>PRO_0000037965</id>
      <dbReference type="UniProtKB" id="P14340"/>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-2462104">
      <id>P55265</id>
    </interactant>
    <interactant intactId="EBI-6858501">
      <id>PRO_0000045599</id>
      <dbReference type="UniProtKB" id="Q99IB8"/>
    </interactant>
    <organismsDiffer>true</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6913056">
      <id>P55265-1</id>
    </interactant>
    <interactant intactId="EBI-395506">
      <id>Q9UPY3</id>
      <label>DICER1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>4</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6913056">
      <id>P55265-1</id>
    </interactant>
    <interactant intactId="EBI-978581">
      <id>Q15633</id>
      <label>TARBP2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6913210">
      <id>P55265-5</id>
    </interactant>
    <interactant intactId="EBI-395506">
      <id>Q9UPY3</id>
      <label>DICER1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>8</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6913210">
      <id>P55265-5</id>
    </interactant>
    <interactant intactId="EBI-978581">
      <id>Q15633</id>
      <label>TARBP2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>3</experiments>
  </comment>
  <comment type="subcellular location">
    <molecule>Isoform 1</molecule>
    <subcellularLocation>
      <location evidence="35">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="34 35">Nucleus</location>
    </subcellularLocation>
    <text evidence="34 35">Shuttles between the cytoplasm and nucleus (PubMed:24753571, PubMed:7565688). Nuclear import is mediated by TNPO1 (PubMed:24753571).</text>
  </comment>
  <comment type="subcellular location">
    <molecule>Isoform 5</molecule>
    <subcellularLocation>
      <location evidence="26">Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="26 35">Nucleus</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="10">Nucleus</location>
      <location evidence="10">Nucleolus</location>
    </subcellularLocation>
    <text evidence="26">Predominantly nuclear but can shuttle between nucleus and cytoplasm. TNPO1 can mediate its nuclear import whereas XPO5 can mediate its nuclear export.</text>
  </comment>
  <comment type="alternative products">
    <event type="alternative promoter"/>
    <event type="alternative splicing"/>
    <isoform>
      <id>P55265-1</id>
      <name>1</name>
      <name>ADAR-a</name>
      <name>ADAR1L</name>
      <name>p150</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>P55265-2</id>
      <name>2</name>
      <name>ADAR-b</name>
      <sequence type="described" ref="VSP_008874"/>
    </isoform>
    <isoform>
      <id>P55265-3</id>
      <name>3</name>
      <name>ADAR-c</name>
      <sequence type="described" ref="VSP_008873 VSP_008874"/>
    </isoform>
    <isoform>
      <id>P55265-4</id>
      <name>4</name>
      <sequence type="described" ref="VSP_008872"/>
    </isoform>
    <isoform>
      <id>P55265-5</id>
      <name>5</name>
      <name>ADAR1S</name>
      <name>p110</name>
      <sequence type="described" ref="VSP_019235"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="24 36">Ubiquitously expressed, highest levels were found in brain and lung (PubMed:7972084). Isoform 5 is expressed at higher levels in astrocytomas as compared to normal brain tissue and expression increases strikingly with the severity of the tumor, being higher in the most aggressive tumors.</text>
  </comment>
  <comment type="induction">
    <text evidence="6 35">Isoform 1 is induced by interferon alpha. Isoform 5 is constitutively expressed.</text>
  </comment>
  <comment type="domain">
    <text evidence="26 34">The third dsRNA-binding domain (DRBM 3) contains an additional N-terminal alpha-helix that is part of a bi-partite nuclear localization signal, together with the sequence immediately C-terminal to DRBM 3. The presence of DRBM 3 is important to bring together the N-terminal and the C-terminal part of the bi-partite nuclear localization signal for import mediated by TNPO1 (PubMed:24753571). RNA binding interferes with nuclear import (PubMed:19124606, PubMed:24753571).</text>
  </comment>
  <comment type="domain">
    <text evidence="2 7 8 19">The first Z-binding domain binds Z-DNA.</text>
  </comment>
  <comment type="PTM">
    <text evidence="18">Sumoylation reduces RNA-editing activity.</text>
  </comment>
  <comment type="disease" evidence="11 12 15">
    <disease id="DI-01510">
      <name>Dyschromatosis symmetrica hereditaria</name>
      <acronym>DSH</acronym>
      <description>An autosomal dominant pigmentary genodermatosis characterized by a mixture of hyperpigmented and hypopigmented macules distributed on the face and the dorsal parts of the hands and feet, that appear in infancy or early childhood.</description>
      <dbReference type="MIM" id="127400"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="disease" evidence="33">
    <disease id="DI-03668">
      <name>Aicardi-Goutieres syndrome 6</name>
      <acronym>AGS6</acronym>
      <description>A form of Aicardi-Goutieres syndrome, a genetically heterogeneous disease characterized by cerebral atrophy, leukoencephalopathy, intracranial calcifications, chronic cerebrospinal fluid (CSF) lymphocytosis, increased CSF alpha-interferon, and negative serologic investigations for common prenatal infection. Clinical features as thrombocytopenia, hepatosplenomegaly and elevated hepatic transaminases along with intermittent fever may erroneously suggest an infective process. Severe neurological dysfunctions manifest in infancy as progressive microcephaly, spasticity, dystonic posturing and profound psychomotor retardation. Death often occurs in early childhood.</description>
      <dbReference type="MIM" id="615010"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 1</molecule>
    <text>Produced by alternative promoter usage.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 2</molecule>
    <text evidence="42">Produced by alternative splicing of isoform 1.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 3</molecule>
    <text evidence="42">Produced by alternative splicing of isoform 1.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 4</molecule>
    <text evidence="42">Produced by alternative splicing of isoform 1.</text>
  </comment>
  <comment type="miscellaneous">
    <molecule>Isoform 5</molecule>
    <text evidence="42">Produced by alternative promoter usage.</text>
  </comment>
  <comment type="caution">
    <text evidence="42">The N-terminus of isoform 4 has been derived from EST and genomic sequences.</text>
  </comment>
  <comment type="sequence caution" evidence="42">
    <conflict type="erroneous termination">
      <sequence resource="EMBL-CDS" id="CAE45853" version="1"/>
    </conflict>
    <text>Extended C-terminus.</text>
  </comment>
  <dbReference type="EC" id="3.5.4.37" evidence="35 36"/>
  <dbReference type="EMBL" id="U10439">
    <property type="protein sequence ID" value="AAB06697.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75503">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75489">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75490">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75491">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75492">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75493">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75494">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75495">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75496">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75497">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75498">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75499">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75500">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75501">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75502">
    <property type="protein sequence ID" value="AAB97116.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75503">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75489">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75490">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75491">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75492">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75493">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75494">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75495">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75496">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75497">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75498">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75499">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75500">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75501">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75502">
    <property type="protein sequence ID" value="AAB97117.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75503">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75489">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75490">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75491">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75492">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75493">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75494">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75495">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75496">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75497">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75498">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75499">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75500">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75501">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U75502">
    <property type="protein sequence ID" value="AAB97118.1"/>
    <property type="status" value="JOINED"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="U18121">
    <property type="protein sequence ID" value="AAC13782.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X79448">
    <property type="protein sequence ID" value="CAA55967.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X79449">
    <property type="protein sequence ID" value="CAA55968.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X98559">
    <property type="protein sequence ID" value="CAA67169.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="X98559">
    <property type="protein sequence ID" value="CAA67170.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BX538232">
    <property type="protein sequence ID" value="CAD98075.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BX640741">
    <property type="protein sequence ID" value="CAE45853.1"/>
    <property type="status" value="ALT_SEQ"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL592078">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL606500">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AL691488">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471121">
    <property type="protein sequence ID" value="EAW53183.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471121">
    <property type="protein sequence ID" value="EAW53187.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC038227">
    <property type="protein sequence ID" value="AAH38227.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS1071.1">
    <molecule id="P55265-1"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS30879.1">
    <molecule id="P55265-5"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS44231.1">
    <molecule id="P55265-2"/>
  </dbReference>
  <dbReference type="PIR" id="S65593">
    <property type="entry name" value="S65593"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001020278.1">
    <molecule id="P55265-5"/>
    <property type="nucleotide sequence ID" value="NM_001025107.2"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001102.2">
    <molecule id="P55265-1"/>
    <property type="nucleotide sequence ID" value="NM_001111.4"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_001180424.1">
    <molecule id="P55265-5"/>
    <property type="nucleotide sequence ID" value="NM_001193495.1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_056655.2">
    <molecule id="P55265-2"/>
    <property type="nucleotide sequence ID" value="NM_015840.3"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_056656.2">
    <molecule id="P55265-3"/>
    <property type="nucleotide sequence ID" value="NM_015841.3"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_006711174.1">
    <property type="nucleotide sequence ID" value="XM_006711111.3"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_006711175.1">
    <property type="nucleotide sequence ID" value="XM_006711112.2"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_006711176.1">
    <property type="nucleotide sequence ID" value="XM_006711113.2"/>
  </dbReference>
  <dbReference type="PDB" id="1QBJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A/B/C=133-209"/>
  </dbReference>
  <dbReference type="PDB" id="1QGP">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=125-200"/>
  </dbReference>
  <dbReference type="PDB" id="1XMK">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="0.97 A"/>
    <property type="chains" value="A=294-366"/>
  </dbReference>
  <dbReference type="PDB" id="2ACJ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.60 A"/>
    <property type="chains" value="A/B/C/D=140-202"/>
  </dbReference>
  <dbReference type="PDB" id="2GXB">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.25 A"/>
    <property type="chains" value="A/B=140-202"/>
  </dbReference>
  <dbReference type="PDB" id="2L54">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=136-198"/>
  </dbReference>
  <dbReference type="PDB" id="2MDR">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=708-801"/>
  </dbReference>
  <dbReference type="PDB" id="3F21">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.20 A"/>
    <property type="chains" value="A/B/C=133-209"/>
  </dbReference>
  <dbReference type="PDB" id="3F22">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.50 A"/>
    <property type="chains" value="A/B/C=133-209"/>
  </dbReference>
  <dbReference type="PDB" id="3F23">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.70 A"/>
    <property type="chains" value="A/B/C=133-209"/>
  </dbReference>
  <dbReference type="PDB" id="3IRQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A/B/C/D=140-202"/>
  </dbReference>
  <dbReference type="PDB" id="3IRR">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.65 A"/>
    <property type="chains" value="A/B/C/D=140-202"/>
  </dbReference>
  <dbReference type="PDB" id="5ZU1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.01 A"/>
    <property type="chains" value="A/B/C/D=140-198"/>
  </dbReference>
  <dbReference type="PDB" id="5ZUO">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="A/B/C/D=140-202"/>
  </dbReference>
  <dbReference type="PDB" id="5ZUP">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.90 A"/>
    <property type="chains" value="A/B/C/D=140-202"/>
  </dbReference>
  <dbReference type="PDB" id="7C0I">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.40 A"/>
    <property type="chains" value="A/B/C=170-184"/>
  </dbReference>
  <dbReference type="PDB" id="7ZJ1">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="1.65 A"/>
    <property type="chains" value="A/B=716-797"/>
  </dbReference>
  <dbReference type="PDB" id="7ZLQ">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.80 A"/>
    <property type="chains" value="A/B=716-797"/>
  </dbReference>
  <dbReference type="PDB" id="8GBC">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=140-202"/>
  </dbReference>
  <dbReference type="PDB" id="8GBD">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=140-202"/>
  </dbReference>
  <dbReference type="PDBsum" id="1QBJ"/>
  <dbReference type="PDBsum" id="1QGP"/>
  <dbReference type="PDBsum" id="1XMK"/>
  <dbReference type="PDBsum" id="2ACJ"/>
  <dbReference type="PDBsum" id="2GXB"/>
  <dbReference type="PDBsum" id="2L54"/>
  <dbReference type="PDBsum" id="2MDR"/>
  <dbReference type="PDBsum" id="3F21"/>
  <dbReference type="PDBsum" id="3F22"/>
  <dbReference type="PDBsum" id="3F23"/>
  <dbReference type="PDBsum" id="3IRQ"/>
  <dbReference type="PDBsum" id="3IRR"/>
  <dbReference type="PDBsum" id="5ZU1"/>
  <dbReference type="PDBsum" id="5ZUO"/>
  <dbReference type="PDBsum" id="5ZUP"/>
  <dbReference type="PDBsum" id="7C0I"/>
  <dbReference type="PDBsum" id="7ZJ1"/>
  <dbReference type="PDBsum" id="7ZLQ"/>
  <dbReference type="PDBsum" id="8GBC"/>
  <dbReference type="PDBsum" id="8GBD"/>
  <dbReference type="AlphaFoldDB" id="P55265"/>
  <dbReference type="SMR" id="P55265"/>
  <dbReference type="BioGRID" id="106617">
    <property type="interactions" value="300"/>
  </dbReference>
  <dbReference type="CORUM" id="P55265"/>
  <dbReference type="DIP" id="DIP-29310N"/>
  <dbReference type="IntAct" id="P55265">
    <property type="interactions" value="109"/>
  </dbReference>
  <dbReference type="MINT" id="P55265"/>
  <dbReference type="STRING" id="9606.ENSP00000357459"/>
  <dbReference type="GlyCosmos" id="P55265">
    <property type="glycosylation" value="4 sites, 2 glycans"/>
  </dbReference>
  <dbReference type="GlyGen" id="P55265">
    <property type="glycosylation" value="10 sites, 2 O-linked glycans (10 sites)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="P55265"/>
  <dbReference type="MetOSite" id="P55265"/>
  <dbReference type="PhosphoSitePlus" id="P55265"/>
  <dbReference type="SwissPalm" id="P55265"/>
  <dbReference type="BioMuta" id="ADAR"/>
  <dbReference type="DMDM" id="313104303"/>
  <dbReference type="jPOST" id="P55265"/>
  <dbReference type="MassIVE" id="P55265"/>
  <dbReference type="PaxDb" id="9606-ENSP00000357459"/>
  <dbReference type="PeptideAtlas" id="P55265"/>
  <dbReference type="ProteomicsDB" id="56826">
    <molecule id="P55265-1"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="56827">
    <molecule id="P55265-2"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="56828">
    <molecule id="P55265-3"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="56829">
    <molecule id="P55265-4"/>
  </dbReference>
  <dbReference type="ProteomicsDB" id="56830">
    <molecule id="P55265-5"/>
  </dbReference>
  <dbReference type="Pumba" id="P55265"/>
  <dbReference type="Antibodypedia" id="1280">
    <property type="antibodies" value="337 antibodies from 33 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="103"/>
  <dbReference type="Ensembl" id="ENST00000368471.8">
    <molecule id="P55265-5"/>
    <property type="protein sequence ID" value="ENSP00000357456.3"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000368474.9">
    <molecule id="P55265-1"/>
    <property type="protein sequence ID" value="ENSP00000357459.4"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000529168.2">
    <molecule id="P55265-2"/>
    <property type="protein sequence ID" value="ENSP00000431794.2"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000648231.2">
    <molecule id="P55265-5"/>
    <property type="protein sequence ID" value="ENSP00000497555.1"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000648311.1">
    <molecule id="P55265-5"/>
    <property type="protein sequence ID" value="ENSP00000498137.1"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000649022.2">
    <molecule id="P55265-5"/>
    <property type="protein sequence ID" value="ENSP00000496896.2"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000649749.1">
    <molecule id="P55265-5"/>
    <property type="protein sequence ID" value="ENSP00000497210.1"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000681683.1">
    <molecule id="P55265-5"/>
    <property type="protein sequence ID" value="ENSP00000506666.1"/>
    <property type="gene ID" value="ENSG00000160710.19"/>
  </dbReference>
  <dbReference type="GeneID" id="103"/>
  <dbReference type="KEGG" id="hsa:103"/>
  <dbReference type="MANE-Select" id="ENST00000368474.9">
    <property type="protein sequence ID" value="ENSP00000357459.4"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_001111.5"/>
    <property type="RefSeq protein sequence ID" value="NP_001102.3"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001ffh.4">
    <molecule id="P55265-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:225"/>
  <dbReference type="CTD" id="103"/>
  <dbReference type="DisGeNET" id="103"/>
  <dbReference type="GeneCards" id="ADAR"/>
  <dbReference type="GeneReviews" id="ADAR"/>
  <dbReference type="HGNC" id="HGNC:225">
    <property type="gene designation" value="ADAR"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000160710">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MalaCards" id="ADAR"/>
  <dbReference type="MIM" id="127400">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="MIM" id="146920">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="MIM" id="615010">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_P55265"/>
  <dbReference type="OpenTargets" id="ENSG00000160710"/>
  <dbReference type="Orphanet" id="51">
    <property type="disease" value="Aicardi-Goutieres syndrome"/>
  </dbReference>
  <dbReference type="Orphanet" id="41">
    <property type="disease" value="Dyschromatosis symmetrica hereditaria"/>
  </dbReference>
  <dbReference type="Orphanet" id="225154">
    <property type="disease" value="Familial infantile bilateral striatal necrosis"/>
  </dbReference>
  <dbReference type="PharmGKB" id="PA24555"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000160710"/>
  <dbReference type="eggNOG" id="KOG2777">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000157243"/>
  <dbReference type="HOGENOM" id="CLU_005382_0_0_1"/>
  <dbReference type="InParanoid" id="P55265"/>
  <dbReference type="OMA" id="ERMQMKR"/>
  <dbReference type="OrthoDB" id="118472at2759"/>
  <dbReference type="PhylomeDB" id="P55265"/>
  <dbReference type="TreeFam" id="TF315806"/>
  <dbReference type="BRENDA" id="3.5.4.37">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="P55265"/>
  <dbReference type="Reactome" id="R-HSA-75102">
    <property type="pathway name" value="C6 deamination of adenosine"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-77042">
    <property type="pathway name" value="Formation of editosomes by ADAR proteins"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-909733">
    <property type="pathway name" value="Interferon alpha/beta signaling"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9833482">
    <property type="pathway name" value="PKR-mediated signaling"/>
  </dbReference>
  <dbReference type="SignaLink" id="P55265"/>
  <dbReference type="SIGNOR" id="P55265"/>
  <dbReference type="BioGRID-ORCS" id="103">
    <property type="hits" value="289 hits in 1164 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="ADAR">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="P55265"/>
  <dbReference type="GeneWiki" id="ADAR"/>
  <dbReference type="GenomeRNAi" id="103"/>
  <dbReference type="Pharos" id="P55265">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:P55265"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 1"/>
  </dbReference>
  <dbReference type="RNAct" id="P55265">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000160710">
    <property type="expression patterns" value="Expressed in endothelial cell and 210 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="P55265">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005730">
    <property type="term" value="C:nucleolus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005634">
    <property type="term" value="C:nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0044530">
    <property type="term" value="C:supraspliceosomal complex"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003677">
    <property type="term" value="F:DNA binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003726">
    <property type="term" value="F:double-stranded RNA adenosine deaminase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003725">
    <property type="term" value="F:double-stranded RNA binding"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0046872">
    <property type="term" value="F:metal ion binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003723">
    <property type="term" value="F:RNA binding"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008251">
    <property type="term" value="F:tRNA-specific adenosine deaminase activity"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006382">
    <property type="term" value="P:adenosine to inosine editing"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016553">
    <property type="term" value="P:base conversion or substitution editing"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0098586">
    <property type="term" value="P:cellular response to virus"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051607">
    <property type="term" value="P:defense response to virus"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060216">
    <property type="term" value="P:definitive hemopoiesis"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0030218">
    <property type="term" value="P:erythrocyte differentiation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002244">
    <property type="term" value="P:hematopoietic progenitor cell differentiation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0061484">
    <property type="term" value="P:hematopoietic stem cell homeostasis"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097284">
    <property type="term" value="P:hepatocyte apoptotic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006397">
    <property type="term" value="P:mRNA processing"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:1903944">
    <property type="term" value="P:negative regulation of hepatocyte apoptotic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:1900369">
    <property type="term" value="P:negative regulation of post-transcriptional gene silencing by regulatory ncRNA"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0044387">
    <property type="term" value="P:negative regulation of protein kinase activity by regulation of protein phosphorylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060339">
    <property type="term" value="P:negative regulation of type I interferon-mediated signaling pathway"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001649">
    <property type="term" value="P:osteoblast differentiation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045070">
    <property type="term" value="P:positive regulation of viral genome replication"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031054">
    <property type="term" value="P:pre-miRNA processing"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006611">
    <property type="term" value="P:protein export from nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006606">
    <property type="term" value="P:protein import into nucleus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035455">
    <property type="term" value="P:response to interferon-alpha"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009615">
    <property type="term" value="P:response to virus"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0070922">
    <property type="term" value="P:RISC complex assembly"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006396">
    <property type="term" value="P:RNA processing"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002566">
    <property type="term" value="P:somatic diversification of immune receptors via somatic mutation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="CDD" id="cd19913">
    <property type="entry name" value="DSRM_DRADA_rpt1"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd19914">
    <property type="entry name" value="DSRM_DRADA_rpt2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="CDD" id="cd19915">
    <property type="entry name" value="DSRM_DRADA_rpt3"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.160.20">
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="Gene3D" id="1.10.10.10">
    <property type="entry name" value="Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002466">
    <property type="entry name" value="A_deamin"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR044456">
    <property type="entry name" value="ADAR1_DSRM_1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR044457">
    <property type="entry name" value="ADAR1_DSRM_3"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR014720">
    <property type="entry name" value="dsRBD_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036388">
    <property type="entry name" value="WH-like_DNA-bd_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR036390">
    <property type="entry name" value="WH_DNA-bd_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR042371">
    <property type="entry name" value="Z_dom"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10910:SF107">
    <property type="entry name" value="DOUBLE-STRANDED RNA-SPECIFIC ADENOSINE DEAMINASE"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR10910">
    <property type="entry name" value="EUKARYOTE SPECIFIC DSRNA BINDING PROTEIN"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02137">
    <property type="entry name" value="A_deamin"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF00035">
    <property type="entry name" value="dsrm"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="Pfam" id="PF02295">
    <property type="entry name" value="z-alpha"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SMART" id="SM00552">
    <property type="entry name" value="ADEAMc"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00358">
    <property type="entry name" value="DSRM"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="SMART" id="SM00550">
    <property type="entry name" value="Zalpha"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF54768">
    <property type="entry name" value="dsRNA-binding domain-like"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF46785">
    <property type="entry name" value="Winged helix' DNA-binding domain"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50141">
    <property type="entry name" value="A_DEAMIN_EDITASE"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50137">
    <property type="entry name" value="DS_RBD"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50139">
    <property type="entry name" value="Z_BINDING"/>
    <property type="match status" value="2"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0948">Aicardi-Goutieres syndrome</keyword>
  <keyword id="KW-0877">Alternative promoter usage</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0051">Antiviral defense</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-0238">DNA-binding</keyword>
  <keyword id="KW-0378">Hydrolase</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0399">Innate immunity</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0479">Metal-binding</keyword>
  <keyword id="KW-0488">Methylation</keyword>
  <keyword id="KW-0507">mRNA processing</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0943">RNA-mediated gene silencing</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <keyword id="KW-0862">Zinc</keyword>
  <feature type="chain" id="PRO_0000171774" description="Double-stranded RNA-specific adenosine deaminase">
    <location>
      <begin position="1"/>
      <end position="1226"/>
    </location>
  </feature>
  <feature type="domain" description="Z-binding 1" evidence="2 7 8 19">
    <location>
      <begin position="133"/>
      <end position="199"/>
    </location>
  </feature>
  <feature type="domain" description="Z-binding 2" evidence="2">
    <location>
      <begin position="293"/>
      <end position="357"/>
    </location>
  </feature>
  <feature type="domain" description="DRBM 1" evidence="4">
    <location>
      <begin position="503"/>
      <end position="571"/>
    </location>
  </feature>
  <feature type="domain" description="DRBM 2" evidence="4">
    <location>
      <begin position="614"/>
      <end position="682"/>
    </location>
  </feature>
  <feature type="domain" description="DRBM 3" evidence="4 34">
    <location>
      <begin position="726"/>
      <end position="794"/>
    </location>
  </feature>
  <feature type="domain" description="A to I editase" evidence="3">
    <location>
      <begin position="886"/>
      <end position="1221"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with Z-DNA" evidence="7 8 19">
    <location>
      <begin position="133"/>
      <end position="202"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="5">
    <location>
      <begin position="208"/>
      <end position="238"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="5">
    <location>
      <begin position="258"/>
      <end position="286"/>
    </location>
  </feature>
  <feature type="region of interest" description="Disordered" evidence="5">
    <location>
      <begin position="574"/>
      <end position="610"/>
    </location>
  </feature>
  <feature type="region of interest" description="N-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal" evidence="34">
    <location>
      <begin position="716"/>
      <end position="725"/>
    </location>
  </feature>
  <feature type="region of interest" description="C-terminal extension of DRBM 3 and constituent of a bi-partite nuclear localization signal" evidence="34">
    <location>
      <begin position="795"/>
      <end position="801"/>
    </location>
  </feature>
  <feature type="compositionally biased region" description="Basic and acidic residues" evidence="5">
    <location>
      <begin position="574"/>
      <end position="597"/>
    </location>
  </feature>
  <feature type="active site" description="Proton donor" evidence="3">
    <location>
      <position position="912"/>
    </location>
  </feature>
  <feature type="binding site" evidence="3">
    <location>
      <position position="910"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="3">
    <location>
      <position position="966"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="3">
    <location>
      <position position="1036"/>
    </location>
    <ligand>
      <name>Zn(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:29105"/>
    </ligand>
  </feature>
  <feature type="modified residue" description="Asymmetric dimethylarginine" evidence="52">
    <location>
      <position position="26"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="1">
    <location>
      <position position="285"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="51">
    <location>
      <position position="481"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="47 48 51">
    <location>
      <position position="601"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="51">
    <location>
      <position position="603"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="47">
    <location>
      <position position="614"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="51">
    <location>
      <position position="629"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="51">
    <location>
      <position position="636"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="44 45 46 48 49 51">
    <location>
      <position position="808"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="51">
    <location>
      <position position="814"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="47">
    <location>
      <position position="823"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphoserine" evidence="47 49 50 51">
    <location>
      <position position="825"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="55">
    <location>
      <position position="384"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="55">
    <location>
      <position position="408"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
    <location>
      <position position="418"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="53">
    <location>
      <position position="418"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="53 54 55">
    <location>
      <position position="418"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="55">
    <location>
      <position position="580"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="55">
    <location>
      <position position="875"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_019235" description="In isoform 5." evidence="41">
    <location>
      <begin position="1"/>
      <end position="295"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_008872" description="In isoform 4." evidence="39">
    <original>MNPRQ</original>
    <variation>MMSPICDQTIDSRLKVEKATWWGRVGGGSRPHWQPPGVRPCPEEVQDP</variation>
    <location>
      <begin position="1"/>
      <end position="5"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_008873" description="In isoform 3." evidence="42">
    <location>
      <begin position="694"/>
      <end position="712"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_008874" description="In isoform 2 and isoform 3." evidence="42">
    <location>
      <begin position="807"/>
      <end position="832"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_048725" description="In dbSNP:rs1466731." evidence="13 23 35 36 37 38">
    <original>R</original>
    <variation>G</variation>
    <location>
      <position position="100"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069535" description="In AGS6; dbSNP:rs145588689." evidence="33">
    <original>P</original>
    <variation>A</variation>
    <location>
      <position position="193"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_017240" description="In dbSNP:rs2229857." evidence="23 35 37 38">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="384"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_024407" description="In dbSNP:rs17843865.">
    <original>Y</original>
    <variation>C</variation>
    <location>
      <position position="587"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_035805" description="In a breast cancer sample; somatic mutation; dbSNP:rs144119808." evidence="21">
    <original>E</original>
    <variation>V</variation>
    <location>
      <position position="806"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069536" description="In AGS6; dbSNP:rs398122893." evidence="33">
    <original>A</original>
    <variation>T</variation>
    <location>
      <position position="870"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069537" description="In AGS6; dbSNP:rs398122897." evidence="33">
    <original>I</original>
    <variation>T</variation>
    <location>
      <position position="872"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069538" description="In AGS6; dbSNP:rs398122892." evidence="33">
    <original>R</original>
    <variation>H</variation>
    <location>
      <position position="892"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_017604" description="In DSH; dbSNP:rs28936680." evidence="11">
    <original>L</original>
    <variation>P</variation>
    <location>
      <position position="923"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_021729" description="In DSH." evidence="12">
    <original>C</original>
    <variation>F</variation>
    <location>
      <position position="966"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069539" description="In AGS6; dbSNP:rs398122896." evidence="33">
    <original>K</original>
    <variation>N</variation>
    <location>
      <position position="999"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069540" description="In AGS6; dbSNP:rs398122822." evidence="33">
    <original>G</original>
    <variation>R</variation>
    <location>
      <position position="1007"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069541" description="In AGS6; dbSNP:rs398122895." evidence="33">
    <original>Y</original>
    <variation>F</variation>
    <location>
      <position position="1112"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_069542" description="In AGS6; dbSNP:rs398122894." evidence="33">
    <original>D</original>
    <variation>H</variation>
    <location>
      <position position="1113"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_026669" description="In DSH; dbSNP:rs1044845711." evidence="15">
    <original>R</original>
    <variation>W</variation>
    <location>
      <position position="1155"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_017605" description="In DSH; dbSNP:rs28936681." evidence="11">
    <original>F</original>
    <variation>S</variation>
    <location>
      <position position="1165"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes sumoylation." evidence="18">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="418"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes nuclear location." evidence="34">
    <location>
      <begin position="708"/>
      <end position="801"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Decreased nuclear and partially cytoplasmic location." evidence="34">
    <original>MMP</original>
    <variation>AMA</variation>
    <location>
      <begin position="708"/>
      <end position="710"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on nuclear location. No effect on RNA binding." evidence="34">
    <original>KVRK</original>
    <variation>AVAA</variation>
    <location>
      <begin position="712"/>
      <end position="715"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Disrupts the bi-partite nuclear localization signal and abolishes nuclear location." evidence="34">
    <location>
      <begin position="716"/>
      <end position="724"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Disrupts the bi-partite nuclear localization signal and abolishes nuclear location; when associated with S-719 and N-723." evidence="34">
    <original>I</original>
    <variation>N</variation>
    <location>
      <position position="716"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on nuclear location; when associated with A-721 and A-724." evidence="34">
    <original>E</original>
    <variation>A</variation>
    <location>
      <position position="718"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Disrupts the bi-partite nuclear localization signal and abolishes nuclear location; when associated with N-716 and N-723." evidence="34">
    <original>L</original>
    <variation>S</variation>
    <location>
      <position position="719"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on nuclear location; when associated with A-721 and A-724." evidence="34">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="721"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Disrupts the bi-partite nuclear localization signal and abolishes nuclear location; when associated with N-716 and S-719." evidence="34">
    <original>L</original>
    <variation>N</variation>
    <location>
      <position position="723"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on nuclear location; when associated with A-718 and A-721." evidence="34">
    <original>N</original>
    <variation>A</variation>
    <location>
      <position position="724"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Disrupts nuclear localization signal. No effect on RNA binding." evidence="34">
    <location>
      <begin position="725"/>
      <end position="801"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Strongly impaired RNA binding. No effect on nuclear location." evidence="34">
    <original>KK</original>
    <variation>AA</variation>
    <location>
      <begin position="777"/>
      <end position="778"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes interaction with TNPO1, TNPO1-mediated nuclear import and nuclear location." evidence="34">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="801"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 4; CAA55968." evidence="42" ref="4">
    <original>E</original>
    <variation>G</variation>
    <location>
      <position position="53"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; CAE45853." evidence="42" ref="5">
    <original>F</original>
    <variation>L</variation>
    <location>
      <position position="245"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; CAE45853." evidence="42" ref="5">
    <original>F</original>
    <variation>L</variation>
    <location>
      <position position="482"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; CAE45853." evidence="42" ref="5">
    <original>I</original>
    <variation>V</variation>
    <location>
      <position position="873"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; CAE45853." evidence="42" ref="5">
    <original>D</original>
    <variation>G</variation>
    <location>
      <position position="1093"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 4; CAA55967/CAA55968/CAA67169/CAA67170." evidence="42" ref="4">
    <original>E</original>
    <variation>K</variation>
    <location>
      <position position="1184"/>
    </location>
  </feature>
  <feature type="helix" evidence="57">
    <location>
      <begin position="127"/>
      <end position="130"/>
    </location>
  </feature>
  <feature type="helix" evidence="56">
    <location>
      <begin position="135"/>
      <end position="150"/>
    </location>
  </feature>
  <feature type="strand" evidence="57">
    <location>
      <begin position="152"/>
      <end position="154"/>
    </location>
  </feature>
  <feature type="helix" evidence="56">
    <location>
      <begin position="158"/>
      <end position="165"/>
    </location>
  </feature>
  <feature type="helix" evidence="56">
    <location>
      <begin position="169"/>
      <end position="181"/>
    </location>
  </feature>
  <feature type="strand" evidence="56">
    <location>
      <begin position="184"/>
      <end position="192"/>
    </location>
  </feature>
  <feature type="strand" evidence="56">
    <location>
      <begin position="194"/>
      <end position="197"/>
    </location>
  </feature>
  <feature type="helix" evidence="58">
    <location>
      <begin position="294"/>
      <end position="309"/>
    </location>
  </feature>
  <feature type="helix" evidence="58">
    <location>
      <begin position="315"/>
      <end position="322"/>
    </location>
  </feature>
  <feature type="helix" evidence="58">
    <location>
      <begin position="324"/>
      <end position="326"/>
    </location>
  </feature>
  <feature type="helix" evidence="58">
    <location>
      <begin position="327"/>
      <end position="339"/>
    </location>
  </feature>
  <feature type="strand" evidence="58">
    <location>
      <begin position="342"/>
      <end position="346"/>
    </location>
  </feature>
  <feature type="strand" evidence="58">
    <location>
      <begin position="348"/>
      <end position="350"/>
    </location>
  </feature>
  <feature type="strand" evidence="58">
    <location>
      <begin position="352"/>
      <end position="355"/>
    </location>
  </feature>
  <feature type="helix" evidence="58">
    <location>
      <begin position="357"/>
      <end position="360"/>
    </location>
  </feature>
  <feature type="turn" evidence="58">
    <location>
      <begin position="361"/>
      <end position="363"/>
    </location>
  </feature>
  <feature type="helix" evidence="59">
    <location>
      <begin position="716"/>
      <end position="721"/>
    </location>
  </feature>
  <feature type="turn" evidence="59">
    <location>
      <begin position="722"/>
      <end position="725"/>
    </location>
  </feature>
  <feature type="helix" evidence="59">
    <location>
      <begin position="727"/>
      <end position="737"/>
    </location>
  </feature>
  <feature type="strand" evidence="59">
    <location>
      <begin position="742"/>
      <end position="751"/>
    </location>
  </feature>
  <feature type="strand" evidence="59">
    <location>
      <begin position="757"/>
      <end position="764"/>
    </location>
  </feature>
  <feature type="strand" evidence="59">
    <location>
      <begin position="772"/>
      <end position="776"/>
    </location>
  </feature>
  <feature type="helix" evidence="59">
    <location>
      <begin position="777"/>
      <end position="795"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; CAE45853." evidence="42" ref="5">
    <original>R</original>
    <variation>G</variation>
    <location sequence="P55265-4">
      <position position="13"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="P55266"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00073"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="3">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00240"/>
    </source>
  </evidence>
  <evidence type="ECO:0000255" key="4">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00266"/>
    </source>
  </evidence>
  <evidence type="ECO:0000256" key="5">
    <source>
      <dbReference type="SAM" id="MobiDB-lite"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="10200312"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="10364558"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="10535945"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="12618436"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="12665561"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="12916015"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="15146470"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="15556947"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="15659327"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="15858013"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="16055709"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="16120648"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="16237447"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="16475990"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="16959974"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="17079286"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="17974005"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="18178553"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="18362360"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="19124606"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source>
      <dbReference type="PubMed" id="19605474"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="28">
    <source>
      <dbReference type="PubMed" id="19651874"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="29">
    <source>
      <dbReference type="PubMed" id="19710021"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="30">
    <source>
      <dbReference type="PubMed" id="19908260"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="31">
    <source>
      <dbReference type="PubMed" id="21289159"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="32">
    <source>
      <dbReference type="PubMed" id="22278222"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="33">
    <source>
      <dbReference type="PubMed" id="23001123"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="34">
    <source>
      <dbReference type="PubMed" id="24753571"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="35">
    <source>
      <dbReference type="PubMed" id="7565688"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="36">
    <source>
      <dbReference type="PubMed" id="7972084"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="37">
    <source>
      <dbReference type="PubMed" id="9020165"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="38">
    <source ref="4"/>
  </evidence>
  <evidence type="ECO:0000303" key="39">
    <source>
      <dbReference type="PubMed" id="17974005"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="40">
    <source>
      <dbReference type="PubMed" id="7972084"/>
    </source>
  </evidence>
  <evidence type="ECO:0000303" key="41">
    <source ref="4"/>
  </evidence>
  <evidence type="ECO:0000305" key="42"/>
  <evidence type="ECO:0007744" key="43">
    <source>
      <dbReference type="PDB" id="2ACJ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="44">
    <source>
      <dbReference type="PubMed" id="16964243"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="45">
    <source>
      <dbReference type="PubMed" id="17924679"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="46">
    <source>
      <dbReference type="PubMed" id="18220336"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="47">
    <source>
      <dbReference type="PubMed" id="18669648"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="48">
    <source>
      <dbReference type="PubMed" id="19690332"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="49">
    <source>
      <dbReference type="PubMed" id="20068231"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="50">
    <source>
      <dbReference type="PubMed" id="21406692"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="51">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="52">
    <source>
      <dbReference type="PubMed" id="24129315"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="53">
    <source>
      <dbReference type="PubMed" id="25114211"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="54">
    <source>
      <dbReference type="PubMed" id="25755297"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="55">
    <source>
      <dbReference type="PubMed" id="28112733"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="56">
    <source>
      <dbReference type="PDB" id="1QBJ"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="57">
    <source>
      <dbReference type="PDB" id="1QGP"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="58">
    <source>
      <dbReference type="PDB" id="1XMK"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="59">
    <source>
      <dbReference type="PDB" id="7ZJ1"/>
    </source>
  </evidence>
  <sequence length="1226" mass="136066" checksum="9CE095D6F9C1BC79" modified="2010-11-30" version="4">MNPRQGYSLSGYYTHPFQGYEHRQLRYQQPGPGSSPSSFLLKQIEFLKGQLPEAPVIGKQTPSLPPSLPGLRPRFPVLLASSTRGRQVDIRGVPRGVHLRSQGLQRGFQHPSPRGRSLPQRGVDCLSSHFQELSIYQDQEQRILKFLEELGEGKATTAHDLSGKLGTPKKEINRVLYSLAKKGKLQKEAGTPPLWKIAVSTQAWNQHSGVVRPDGHSQGAPNSDPSLEPEDRNSTSVSEDLLEPFIAVSAQAWNQHSGVVRPDSHSQGSPNSDPGLEPEDSNSTSALEDPLEFLDMAEIKEKICDYLFNVSDSSALNLAKNIGLTKARDINAVLIDMERQGDVYRQGTTPPIWHLTDKKRERMQIKRNTNSVPETAPAAIPETKRNAEFLTCNIPTSNASNNMVTTEKVENGQEPVIKLENRQEARPEPARLKPPVHYNGPSKAGYVDFENGQWATDDIPDDLNSIRAAPGEFRAIMEMPSFYSHGLPRCSPYKKLTECQLKNPISGLLEYAQFASQTCEFNMIEQSGPPHEPRFKFQVVINGREFPPAEAGSKKVAKQDAAMKAMTILLEEAKAKDSGKSEESSHYSTEKESEKTAESQTPTPSATSFFSGKSPVTTLLECMHKLGNSCEFRLLSKEGPAHEPKFQYCVAVGAQTFPSVSAPSKKVAKQMAAEEAMKALHGEATNSMASDNQPEGMISESLDNLESMMPNKVRKIGELVRYLNTNPVGGLLEYARSHGFAAEFKLVDQSGPPHEPKFVYQAKVGGRWFPAVCAHSKKQGKQEAADAALRVLIGENEKAERMGFTEVTPVTGASLRRTMLLLSRSPEAQPKTLPLTGSTFHDQIAMLSHRCFNTLTNSFQPSLLGRKILAAIIMKKDSEDMGVVVSLGTGNRCVKGDSLSLKGETVNDCHAEIISRRGFIRFLYSELMKYNSQTAKDSIFEPAKGGEKLQIKKTVSFHLYISTAPCGDGALFDKSCSDRAMESTESRHYPVFENPKQGKLRTKVENGEGTIPVESSDIVPTWDGIRLGERLRTMSCSDKILRWNVLGLQGALLTHFLQPIYLKSVTLGYLFSQGHLTRAICCRVTRDGSAFEDGLRHPFIVNHPKVGRVSIYDSKRQSGKTKETSVNWCLADGYDLEILDGTRGTVDGPRNELSRVSKKNIFLLFKKLCSFRYRRDLLRLSYGEAKKAARDYETAKNYFKKGLKDMGYGNWISKPQEEKNFYLCPV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>